Stephen V Liu
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Stephen V Liu
Jul 26, 2024, 06:20 |
Blog
Hossein Borghaei discusses how CTLA4 remains relevant for NSCLC at DC Lung24
Stephen V Liu shared on X: "Dr. Hossein Borghaei from Fox Chase Cancer Center discusses how…
Jul 26, 2024, 00:27 |
Blog
Stephen V Liu: Rapid communication on management of stage III NSCLC by ASCO
Stephen V Liu shared on X: "Latest ASCO rapid communication on management of stage III NSCLC.…
Jul 25, 2024, 21:48 |
Insight
Stephen V Liu: What is the role for SRS to brain metastases up front for EGFR or ALK NSCLC?
Stephen V Liu shared a paper by Luke R.G. Pike et al. on X, adding: “What…
Jul 25, 2024, 14:28 |
Blog
Stephen V Liu: Alexander Drilon joins DCLung24 to discuss RET fusions in NSCLC
Stephen V Liu shared on X: "Dr. Alexander Drilon joins DCLung24 to discuss RET fusions as…
Jul 24, 2024, 00:57 |
Insight
Report on TROP2 expression across tumors
Stephen V Liu shared a paper by Dan Morgenstern-Kaplan et al, on X: "Report on…
Jul 23, 2024, 11:45 |
Blog
Stephen V Liu: The International Lung Cancer Survivorship Conference is on September 20-21,2024
Stephen V Liu shared on X: "Join me at ILCSC24 on Sept 20 - 21 with…
Jul 21, 2024, 15:37 |
Insight
Neoadjuvant osimertinib for resectable EGFR NSCLC
Stephen V Liu shared on X a recent paper by Collin M. Blakely et al.…
Jul 21, 2024, 09:29 |
Blog
Stephen V Liu: Terri Conneran about the patient perspective on the value of research at DC Lung 24
Stephen V Liu shared on X: . "Excited to welcome Terri Conneran of KRAS Kickers to…
Jul 20, 2024, 17:09 |
Opinion
Stephen V Liu: Tina Cascone on Neoadjuvant and Perioperative Immunotherapy For Early Stage NSCLE At DCLung24
Stephen V Liu shared a post on X: "Dr. Tina Cascone from MD Anderson News…
Jul 20, 2024, 01:22 |
Blog
Brigatinib in ROS1 NSCLC
Stephen V Liu shared a post on X: ''Brigatinib in ROS1 NSCLC (Phase II Barossa…
Jul 18, 2024, 11:08 |
Blog
Stephen V Liu: Retrospective study looks at immunotherapy in patients with NSCLC and autoimmune condition
Stephen V Liu shared on X: "Retrospective NEJ047 study looks at immunotherapy in patients with NSCLC…
Jul 13, 2024, 14:20 |
Blog
Samuel Kareff: Pan-tumoral analysis of TROP2 among solid tumors
Samuel Kareff, Hematology/Oncology Chief Fellow at the University of Miami Sylvester Comprehensive Cancer Center, shared…
Jul 10, 2024, 11:53 |
Blog
Stephen V. Liu: Pittsburgh Annual Oncology Symposium Experts and Evidence 2024
Stephen V. Liu shared on X: “Join me for an update on Targeted Therapy in…
Jul 8, 2024, 18:02 |
Blog
Stephen V. Liu: Brief update at utilization of lung cancer screening in the US
Stephen V. Liu shared on X: “Brief update at utilization of lung cancer screening in…
Jul 7, 2024, 17:51 |
Blog
Stephen V. Liu: How do we encourage colleagues and patients to wait for biomarker results?
Stephen V. Liu shared on X: “Faced with an urgency to start therapy for newly…
Jul 7, 2024, 07:04 |
Blog
Stephen V. Liu: Can we use ctDNA to personalize use of consolidation immunotherapy after chemoradiation?
Stephen V. Liu shared on X: “Can we use ctDNA to personalize use of consolidation…
Jul 6, 2024, 12:06 |
Blog
Real world data on QTc prolongation with osimertinib
Stephen V Liu shared on X: "Real world data on QTc prolongation with osimertinib. 970 pts…
Jul 5, 2024, 10:25 |
Blog
Stephen V Liu: Important dates for thoracic oncologists
Stephen V Liu shared on X: "For all thoracic oncologists out there, keep these dates…
Jul 5, 2024, 06:54 |
Blog
Estela Rodriguez: Underreported toxicity of myopathy from EGFR TKIs
Estela Rodriguez shared a post by Stephen V Liu, on X: "Important to study under reported toxicity…
Jul 4, 2024, 11:48 |
Insight
The Importance of Waiting for Biomarker Results in NSCLC
IASLC (International Association for the Study of Lung Cancer) shared a post on X: "Biomarkers…
Jul 3, 2024, 01:51 |
Blog
Oncology Brothers: Stephen V Liu covering NSCLC where treatment is with curative intent
Oncology Brothers shared on X: "Stephen V Liu from Georgetown Lombardi covering NSCLC where treatment is…
Jul 2, 2024, 15:14 |
Insight
Managing dose reduction without compromising outcomes of HR+ breast cancer
Stephen V Liu shared a post on X: “At the Upstate NY Cancer Symposium, Stephanie Graff…
Jul 1, 2024, 03:08 |
Blog
Stephen V Liu: Phase III Adjuvant BR.31 study does not meet primary endpoint
Stephen V Liu shared on X: “Phase III ADJUVANT BR.31 study does not meet primary…
Jun 23, 2024, 10:44 |
Blog
IV vs Subcutaneous amivantamab in EGFR NSCLC
Eric K. Singhi shared a post by Stephen V Liu, on X: "Absolutely agree with this! Compared with…
Jun 22, 2024, 09:57 |
Blog
Upstate Cancer Symposium: June 29th and 30th - Oncology Brothers
Oncology Brothers shared a post on X: . "Upstate NY Cancer…
Jun 21, 2024, 04:59 |
Insight
Jarushka Naidoo: WCLC24 is fast approaching
Jarushka Naidoo shared a post by IASLC on X, adding: “WCLC24 is fast approaching! Look…
Jun 19, 2024, 03:53 |
Societies
This year's ILCS24 will include a remarkable and global faculty
International Lung Cancer Summit (ILCS) shared on X: "This year's ILCS24 will include a remarkable…
Jun 19, 2024, 02:03 |
Blog
Stephen V Liu: Apply for the IASLC 10th Edition Staging and Prognostic Factors Group
Stephen V Liu shared a post on X: "Apply for the IASLC 10th Edition Staging and…
Jun 19, 2024, 01:35 |
Blog
Stephen V Liu: Bittersweet day at Georgetown Lombardi Comprehensive Cancer Center as Jennifer Marks has her last thoracic clinic with me
Stephen V Liu shared a post on X: “Bittersweet day at Georgetown Lombardi Comprehensive Cancer…
Jun 15, 2024, 05:08 |
Blog
Kelsey Pan: Happy to share our analysis of NSCLC patients with germline EGFR mutations
Kelsey Pan, Heme/Onc Chief Fellow at MD Anderson Cancer Center, shared a post by Stephen V Liu, on…
Jun 14, 2024, 15:12 |
Blog
Stephen V Liu: Second episode of the IASLC podcast
Stephen V Liu shared on X: " So much lung cancer data from ASCO24 we…
Jun 14, 2024, 03:35 |
Blog
Stephen V Liu: ASCO24 highlights with Drs. Lecia Sequist and David R. Spigel
Stephen V Liu shared the following on X: “In the latest episode of the IASLC…
Jun 13, 2024, 07:33 |
Blog
Narjust Florez: Stay tuned for a discussion on lung cancer data presented at ASCO24
Narjust Florez shared a post on X: "Stay tuned for an incredible discussion about the lung…
Jun 9, 2024, 01:38 |
Insight
Stephen V Liu reflects on OS from PACIFIC-R
Stephen V Liu shared the following insight on X: "OS from PACIFIC-R: real-world outcomes with…
Jun 1, 2024, 14:46 |
Societies
15 Posts From ASCO24 Day 1 You Should Not Miss!
The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting is being held from May…
May 26, 2024, 08:37 |
Blog
Giannis Mountzios: New Edition of the ESMO Essentials in Thoracic Oncology has officially kicked-off
Giannis Mountzios, Medical Oncologist at the Department of Medical Oncology in the Air Force General Hospital…
May 21, 2024, 05:50 |
Insight
Stephen V Liu: Lots of great work at the WCLC24 planning meeting
Stephen V Liu, Director of Thoracic Oncology and Developmental Therapeutics at Georgetown University at Lombardi…
May 8, 2024, 00:58 |
Blog
Stephen V Liu: Dr. Passiglia Fra at Rome Lung 24 illustrates the limited role of immunotherapy in driver positive NSCLC
Stephen V Liu, Director of Thoracic Oncology and Developmental Therapeutics at Georgetown University at Lombardi…
May 8, 2024, 00:50 |
Blog
Stephen V Liu: Dr. Giulia Pasello at Rome Lung 24 discusses duration of immunotherapy for NSCLC
Stephen V Liu, Director of Thoracic Oncology and Developmental Therapeutics at Georgetown University at Lombardi…
May 2, 2024, 14:14 |
Blog
Stephen V Liu discusses KRAS mutant NSCLC with Veluswamy and Mariana Brandao - IASLC
International Association for the Study of Lung Cancer (IASLC) shared on X: “KRAS mutations are…
Apr 26, 2024, 19:43 |
Opinion
Stephen V Liu: Early registration is open for WCLC24!
Stephen V Liu, Director of Thoracic Oncology and Developmental Therapeutics at Lombardi Comprehensive Cancer Center,…
Apr 26, 2024, 17:36 |
Blog
Heidi Nafman-Onda: Starstruck at Texaslung24
Heidi Nafman-Onda, Fitness Trainer, Health Educator, Lung Cancer survivor/advocate, Co-Founder of The White Ribbon Project,…
Apr 26, 2024, 15:14 |
Blog
Stephen V Liu: Narjust Florez at TexasLung24 explains why and how social media can help the practicing oncologist
Stephen V Liu, Director of Thoracic Oncology and Developmental Therapeutics at Georgetown University, shared a post on…
Apr 13, 2024, 12:35 |
Opinion
Stephen V Liu: Some guidance on the management of adverse events with sotorasib in KRAS G12C NSCLC Lung Cancer Journal
Stephen V Liu, Director of Thoracic Oncology and Developmental Therapeutics at Georgetown University, shared a post…
Apr 13, 2024, 07:50 |
Blog
Stephen Liu: Help identify areas of ongoing need and provide greater understanding of how we can impact DEI
Stephen V Liu, Director of Thoracic Oncology and Developmental Therapeutics at Lombardi Comprehensive Cancer Center,…
Mar 31, 2024, 23:12 |
Insight
Stephen V Liu: Results from phase III CONTACT-01 trial Journal of Clinical Oncology
Stephen V Liu, Director of Thoracic Oncology and Developmental Therapeutics at Lombardi Comprehensive Cancer Center,…
Mar 30, 2024, 14:25 |
Blog
Stephen V Liu Leads Top Influencers at ELCC 2024 by LARVOL
LARVOL/X recently shared a list of top influencers and their impact from ELCC 2024, where…
Mar 27, 2024, 14:11 |
Blog
Stephen V Liu: ELCC24 Great discussion of Antibody drug conjugates toxicity from Dr. Jarushka Naidoo, noting that each component of the antibody drug conjugate will impact toxicity
Mar 25, 2024, 15:15 |
Societies
25 Posts Not To Miss From ELCC 2024
The European Lung Cancer Congress (ELCC 2024) took place in Prague, Czech Republic, from 20th…
Mar 21, 2024, 15:19 |
Blog
Jarushka Naidoo: Getting ready to plan ASCO24
Jarushka Naidoo shared a post on X/Twitter: “Getting ready to plan ASCO24! And with a…
Mar 11, 2024, 18:00 |
Societies
Florez Lab: A fantastic discussion on Nivolumab and Non-Small Cell Lung Cancer
Florez Lab posted on X/Twitter: "What podcast should you listen to today? In this episode…
Mar 5, 2024, 00:54 |
Blog
Stephen V. Liu: Report Clinical Lung Cancer shows improving lung cancer survival in the Veterans Administration
Stephen V. Liu, Director of Thoracic Oncology and Developmental Therapeutics at Lombardi Comprehensive Cancer Center,…
Feb 25, 2024, 15:08 |
Blog
Christine Garcia: Enjoyed this episode on the past 3 years of the IASLC LCC podcast
Christine Garcia, Director of the Hematology and Oncology Fellowship Program at Weill Cornell Medicine, shared…
Feb 5, 2024, 11:27 |
Insight
Stephen V Liu: The optimal strategy for unresectable stage III NSCLC after chemoradiation in EGFR mutant NSCLC
Stephen V Liu, Director of Thoracic Oncology and Developmental Therapeutics at Lombardi Comprehensive Cancer Center,…
Jan 30, 2024, 10:56 |
Blog
Stephen V Liu: Congratulations to Drs. Glenn J. Hanna, Annie Silk and team - huge achievement!
Stephen V Liu, Director of Thoracic Oncology and Developmental Therapeutics at Lombardi Comprehensive Cancer Center,…
Jan 16, 2024, 05:48 |
Drugs
Stephen V Liu: Many updates in the 1.2024 National Comprehensive Cancer Network (NCCN) NSCLC guidelines
Stephen V Liu, Director of Thoracic Oncology and Developmental Therapeutics at Lombardi Comprehensive Cancer Center,…
Jan 10, 2024, 12:36 |
Blog
,
Drugs
Stephen V Liu: Need more data on PKs with crushing TKI pills
Stephen V Liu, Director of Thoracic Oncology and Developmental Therapeutics at Lombardi Comprehensive Cancer Center,…
Jan 8, 2024, 14:29 |
Blog
Stephen V Liu: I discuss managing relapsed Small-Cell Lung Cancer with Fiona Blackhall and Misty Dawn Shields
Stephen V Liu, Director of Thoracic Oncology and Developmental Therapeutics at the Lombardi Comprehensive Cancer…
Dec 13, 2023, 17:12 |
Blog
Chul Kim: It truly takes a village to conduct and care for patients in clinical trials
Chul Kim, Thoracic Medical Oncologist at Georgetown University, shared on X/Twitter: "It truly takes a…
Nov 28, 2023, 18:00 |
Drugs
Stephen V Liu: Report on real world efficacy and safety of amivantamab including off label use
Stephen V Liu, Director of Thoracic Oncology and Developmental Therapeutics at the Lombardi Comprehensive Cancer…
Nov 14, 2023, 18:53 |
Blog
Narjust Florez: Stephen V Liu discusses a REALISTIC approach to working with our patients and their families while waiting for biomarker testing
Narjust Florez, shared a post on X/Twitter: "Dr. Stephen V Liu discusses a REALISTIC approach…
Oct 24, 2023, 13:45 |
Blog
Stephen V Liu: ESMO23 - Dr. Solange Peters presents the PERLA randomized phase II study
Quoting Stephen V Liu, Associate Professor of Medicine and the Director of Thoracic Oncology at Georgetown University,…
Oct 17, 2023, 16:44 |
Insight
Stephen V Liu reflected on the OCEAN study published in the Journal of Thoracic Oncology
Quoting Stephen V Liu, Associate Professor of Medicine and the Director of Thoracic Oncology at Georgetown…
Oct 10, 2023, 15:47 |
Opinion
Jill Feldman: The true art of oncology is understanding that the right approach/treatment MUST align with the soul, preferences and dreams of the patient (and fam) in front of you.
Sep 11, 2023, 18:17 |
Blog
Stephen V Liu: Dr. Eric Lim's presentation of MARS2 was the best presentation I think I have ever seen.
Quoting Stephen V Liu, Associate Professor of Medicine and the Director of Thoracic Oncology at Georgetown…
Sep 11, 2023, 17:32 |
Blog
Neal Augenstein: As a journalist and lung cancer patient, here’s an example of the power of podcast.
Quoting Neal Augenstein on X/Twitter: ''As a journalist and lung cancer patient, here’s an example of…
Sep 10, 2023, 22:55 |
Blog
Stephen V Liu: Big congratulations to Dr. Suresh Ramalingam - winner of the IASLC Paul Bunn Scientific Award at World Conference on Lung Cancer 2023.
Quoting Stephen V Liu, Director of Thoracic Oncology & Developmental Therapeutics at Georgetown Lombardi, on…
Sep 7, 2023, 19:58 |
Insight
Vivek Subbiah: Super delighted to Join Dr. Stephen V Liu to share my thoughts...
Quoting Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, on…
Aug 29, 2023, 18:57 |
Blog
Stephen V Liu: Join me in Singapore (or virtually) for WCLC23 on Saturday, September 9th.
Quoting Stephen V Liu, the Director of Thoracic Oncology & Developmental Therapeutics Lombardi Comprehensive Cancer…
Aug 13, 2023, 08:56 |
Insight
Stephen V Liu: More data showing the importance of *waiting* for NGS results before starting non–small-cell lung cancer therapy whenever possible!
As per Stephen V. Liu, the Director of Thoracic Oncology and Head of Developmental Therapeutics at…
Aug 12, 2023, 15:49 |
Insight
Stephen V Liu: Editorial New England Journal of Medicine from Dr. Christine Lovly, gives nice perspective on the phase III KEYNOTE 671 study in resectable non-small-cell lung cancer
Jul 5, 2023, 05:23 |
Drugs
Cancer drug shortages continue - Stephen V Liu
Cancer drug shortages continue. Carboplatin, cisplatin, capecitabine, methotrexate, azacitadine - the list continues to grow…
All:
72
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube